By Dara Katcher Levy –
FDA’s Division of Drug Marketing, Advertising, and Communications (“DDMAC”) has announced that it will be holding a series of Enforcement Webinars that will provide an opportunity for attendees to ask DDMAC questions about the Warning and Untitled Letters it issues each quarter. This pilot program “will support DDMAC’s mission to protect the public health by assuring prescription drug information is truthful, balanced and accurately communicated.”
The first of its programs will be held on May 3, 2011, from 2:00 to 2:30 p.m. (ET) and will cover Warning and Untitled Letters issued by DDMAC from January 2011 to April 2011. Given that the Webinar will only be a half hour, it is unclear whether DDMAC will be able to respond to all questions from attendees. We note that DDMAC has issued 4 Letters between January and April 2011, down from 18 Letters issued between January and April 2010. We will see whether DDMAC will plan for longer webinars in the future, where the number of Letters issued in a given quarter may be greater than 4.
The web address for the webinar is: https://collaboration.fda.gov/ddmac1/
Hat tip, Patrick O'Brien